TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside [Seeking Alpha]
A Look At TG Therapeutics (TGTX) Valuation After New US$750 Million Credit Facility [Yahoo! Finance]
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million
This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop [Yahoo! Finance]
BRIUMVI Momentum Leads to Strong Execution for TG Therapeutics (TGTX) [Yahoo! Finance]